about
Strategies to modulate the immune system in breast cancer: checkpoint inhibitors and beyondLong-term survival and BRCA status in male breast cancer: a retrospective single-center analysis.Features of aggressive breast cancer.Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies.Long-term disease control with lapatinib and capecitabine in a patient with HER2-positive metastatic breast cancer pretreated with trastuzumab and trastuzumab-emtansine.Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study.Chemotherapy versus endocrine therapy as first-line treatment in patients with luminal-like HER2-negative metastatic breast cancer: A propensity score analysis.
P50
Q28077815-EE88125D-8DA5-4BEE-94DD-F460A73DB359Q36067806-67D8AB16-9524-4B8F-A3BA-87C886A4AACDQ38542952-565DF0BA-3BD6-4C62-9101-B7743C831F23Q38651951-1A5EA0AE-8670-4A8C-A56E-EB7ECFC84D60Q43572069-696FF3F6-31A3-41C1-86AB-BE4B07D5B828Q48274719-FF13C39C-5ABB-4597-A7B1-DEF3B1BC2FC8Q48935764-E06AFE11-D3E3-4EE7-BCE7-B7342917B6DC
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Monica Milano
@en
Monica Milano
@nl
type
label
Monica Milano
@en
Monica Milano
@nl
prefLabel
Monica Milano
@en
Monica Milano
@nl
P31
P496
0000-0003-0983-1604